MARKET

COEP

COEP

Coeptis Therapeutics Inc
NASDAQ
14.76
-0.03
-0.20%
Opening 13:35 01/06 EST
OPEN
15.00
PREV CLOSE
14.79
HIGH
15.00
LOW
14.60
VOLUME
19.48K
TURNOVER
--
52 WEEK HIGH
21.41
52 WEEK LOW
3.800
MARKET CAP
78.82M
P/E (TTM)
-4.2476
1D
5D
1M
3M
1Y
5Y
1D
Coeptis Therapeutics S-4 declared effective by SEC
TipRanks · 5h ago
Coeptis Therapeutics' SEC-Approved S-4 Clears Path For Z Squared Merger, Stockholder Vote Set For January 30
Benzinga · 5h ago
Coeptis Therapeutics S-4 for Z Squared Merger Declared Effective by SEC
Reuters · 6h ago
COEPTIS THERAPEUTICS S-4 DECLARED EFFECTIVE BY SEC, PROXY MAILING BEGINS IN ANTICIPATION OF THE MERGER TRANSACTION WITH Z SQUARED
Reuters · 6h ago
Press Release: Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
Dow Jones · 6h ago
Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
Barchart · 12h ago
Weekly Report: what happened at COEP last week (1229-0102)?
Weekly Report · 1d ago
Weekly Report: what happened at COEP last week (1222-1226)?
Weekly Report · 12/29/2025 10:11
More
About COEP
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company. The Company is focused on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed by the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and robotic process automation capabilities. The Company’s subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.

Webull offers Coeptis Therapeutics Holdings Inc stock information, including NASDAQ: COEP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COEP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COEP stock methods without spending real money on the virtual paper trading platform.